Location History:
- Kanagawa, JP (2015)
- Shinagawa-ku, JP (2018)
- Tokyo, JP (2019 - 2021)
- Kita-ku, JP (2022)
Company Filing History:
Years Active: 2015-2022
Title: Unveiling Innovator Katsuhiro Kobayashi from Tokyo
Introduction:
Katsuhiro Kobayashi, a prolific inventor based in Tokyo, Japan, has made significant contributions in the field of pharmaceuticals through his groundbreaking patents.
Latest Patents:
Kobayashi's recent patents include the EP300/CREBBP inhibitor, a compound that demonstrates exceptional histone acetyl transferase inhibitory activity against EP300 and/or CREBBP. Additionally, he has developed pyridone derivatives with tetrahydropyranylmethyl groups, which possess the ability to inhibit Axl and are particularly valuable in treating diseases associated with Axl hyperfunction.
Career Highlights:
Katsuhiro Kobayashi is a distinguished member of Daiichi Sankyo Company, Limited, a renowned pharmaceutical company recognized for its innovative drug development efforts.
Collaborations:
Throughout his career, Kobayashi has collaborated closely with esteemed colleagues such as Masahiro Ota and Takeshi Jimbo, further enhancing his impact in the field of pharmaceutical inventions.
Conclusion:
Inventor Katsuhiro Kobayashi's relentless pursuit of innovation and his significant patent portfolio underscore his status as a leading figure in the pharmaceutical industry, shaping the landscape of drug discovery and development for the betterment of healthcare globally.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.